Home

Ponoi II Management, LLC

CIK 1746488 · last filed 2024-04-08

Ponoi II Management, LLC is a corporate insider who has filed 15 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for NGM, was dated Apr 8, 2024. Across all open-market trades the lifetime net is −$699.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $595.6M across reported positions. The firm reports its address in San Francisco, CA. 92 SEC filings were submitted jointly with Tim Kutzkey.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$595.62M

Companies

3

Total Filings

15

Lifetime Open-Market Net

-$699.31M

Filer Profile

Reported Address
1 LETTERMAN DRIVE
BUILDING D, SUITE M-900
SAN FRANCISCO, CA 94129
Phone
(415) 865-2050
State of Incorporation
DE
Related Filers
Tim Kutzkey — 92 joint filings, latest 2024-12-23
Ponoi Capital II, LP — 92 joint filings, latest 2024-12-23
PONOI CAPITAL, LP — 91 joint filings, latest 2024-12-23
Ponoi Management, LLC — 91 joint filings, latest 2024-12-23
COLUMN GROUP II, LP — 80 joint filings, latest 2024-12-23
Column Group II GP, LP — 80 joint filings, latest 2024-12-23
COLUMN GROUP L P — 72 joint filings, latest 2024-04-08
Column Group Management LP — 62 joint filings, latest 2024-04-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted 10%+ Owner 0 $1.54 $0 $78.26M 11 2024-04-08
RAPT Therapeutics, Inc. (RAPT) Delisted 10%+ Owner 375,178 $58.01 $21.76M -$113.48M 2 2021-09-29
RVMD 10%+ Owner 2,836,037 $210.02 $595.62M -$664.10M 2 2020-11-18

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-04-08 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Mixed −217,424,130 $0 EDGAR
2022-10-31 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +768,770 $3.74M EDGAR
2022-05-13 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +1,663,500 $19.02M EDGAR
2021-09-29 RAPT Therapeutics, Inc. (RAPT) Delisted Mixed — -$705.8K EDGAR
2020-11-18 RVMD Sell (S) −18,244,404 -$664.10M EDGAR
2020-08-19 RAPT Therapeutics, Inc. (RAPT) Delisted Sell (S) −4,847,886 -$110.29M EDGAR
2020-08-03 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +7,320 $131.7K EDGAR
2020-06-19 RVMD Other (J) +65,106 $0 EDGAR
2019-10-11 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +531,720 $5.55M EDGAR
2019-08-09 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +2,246,640 $31.45M EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.